U.S. markets closed

Tyme Technologies, Inc. (TYME)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.35000.0000 (0.00%)
At close: 04:00PM EDT
0.3550 +0.00 (+1.43%)
After hours: 06:19PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Bottom Triangle

Bottom Triangle

Previous Close0.3500
Bid0.3500 x 1800
Ask0.3597 x 2200
Day's Range0.3401 - 0.3635
52 Week Range0.2190 - 1.1600
Avg. Volume1,333,340
Market Cap60.272M
Beta (5Y Monthly)0.90
PE Ratio (TTM)N/A
EPS (TTM)-0.1370
Earnings DateNov 07, 2022 - Nov 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for TYME

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Tyme Technologies, Inc.
    Daily – Vickers Top Buyers & Sellers for 10/22/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    10 months agoArgus Research
View more
  • American City Business Journals

    Mass. M&A activity picks up among life sciences firms

    Mergers and acquisitions are starting to ramp up in Massachusetts' life sciences sector, but analysts believe the biggest buys are still yet to come.

  • American City Business Journals

    Syros to acquire New Jersey biotech Tyme Technologies

    Syros Pharmaceuticals is set to acquire a New Jersey biotech firm called Tyme Technologies Inc., extending its cash runway into 2025 at a time when biotech stocks are being hammered.

  • Benzinga

    TYME Technologies Shares Surge On Merger Agreement With Syros Pharma

    Syros Pharmaceuticals Inc (NASDAQ: SYRS) has agreed to acquire TYME Technologies Inc (NASDAQ: TYME), including its pipeline assets and net cash, after accounting for wind-down and transaction expenses currently estimated to be approximately $60 million. Syros expects to issue approximately 74.3 million shares. TYME stockholders are expected to receive approximately 0.4312 shares of Syros shares for each share of TYME share. The combined company will be led by Syros' existing management team, inc